Viewing Study NCT05233033


Ignite Creation Date: 2025-12-25 @ 3:01 AM
Ignite Modification Date: 2026-01-08 @ 9:26 AM
Study NCT ID: NCT05233033
Status: COMPLETED
Last Update Posted: 2024-12-10
First Post: 2022-01-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety, PK/PD, and Clinical Activity of KT-413 in Adult Patients with Relapsed or Refractory B-cell NHL
Sponsor: Kymera Therapeutics, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Non Hodgkin Lymphoma View
None Diffuse Large B Cell Lymphoma View
None DLBCL View
None MYD88 Gene Mutation View
Keywords: